TITLE

Control of Heparin Therapy

AUTHOR(S)
Pitney, W. R.; Pettit, J. E.; Armstrong, Lyn
PUB. DATE
October 1970
SOURCE
British Medical Journal;10/18/1970, Vol. 4 Issue 4728, p139
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64321674

 

Related Articles

  • Guidelines for heparin therapy. Genton, Edward; Genton, E // Annals of Internal Medicine;Jan74, Vol. 80 Issue 1, p77 

    Presents guidelines for heparin therapy. Anticoagulant mechanisms of heparin; Route of heparin administration; Counteraction of heparin effect.

  • The risk of venous clots and heparin therapy. Ferraro, Julia // RN;Dec96, Vol. 59 Issue 12, p16 

    Shows the effectiveness of heparin in controlling deep vein thromboembolism for patients who had total hip replacement. Comparison of this therapy from placebos; Cost effectiveness of the therapy.

  • HIV Infection Increases the Risk of Heparin-Induced Thrombocytopenia. Thompson III, George R.; Lawrence, Valerie A.; Crawford, George E. // Clinical Infectious Diseases;11/15/2007, Vol. 45 Issue 10, p1393 

    The incidence of heparin-induced thrombocytopenia in human immunodeficiency virus (HIV)-infected inpatients was compared with that in a control group that was not known to be infected with HIV in a retrospective cohort study. HIVinfected patients receiving heparin therapy, especially...

  • Delayed-onset heparin-induced thrombocytopenia and thrombosis. Warkentin, Theodore E.; Kelton, John G.; Warkentin, T E; Kelton, J G // Annals of Internal Medicine;10/2/2001, Vol. 135 Issue 7, p502 

    Background: Heparin-induced thrombocytopenia is a prothrombotic drug reaction caused by platelet-activating antibodies that recognize complexes of platelet factor 4 and heparin.Objective: To describe a syndrome termed delayed-onset heparin-induced thrombocytopenia, in...

  • Multicenter study on hemorrhagic risk of heparin bridging therapy for periendoscopic thromboprophylaxis. Mio Matsumoto; Katsuhiro Mabe; Momoko Tsuda; Masayoshi Ono; Saori Omori; Masakazu Takahashi; Takeshi Yoshida; Shoko Ono; Manabu Nakagawa; Soichi Nakagawa; Yuichi Shimizu; Takahiko Kudo; Naoya Sakamoto; Mototsugu Kato // BMC Gastroenterology;Jul2015, Vol. 15 Issue 1, p1 

    Background: For endoscopic interventions, heparin bridging therapy is recommended in patients who are at high risk from interruption of antithrombotic therapy. Although heparin bridging has been reported to be effective in preventing thrombosis, several reports have raised concerns about...

  • Heparin-associated Thrombocytopenia. King, Derek J.; Kelton, John G. // Annals of Internal Medicine;Apr84, Vol. 100 Issue 4, p535 

    Presents a study which examined the occurrence of thrombocytopenia in patients receiving heparin therapy. Complications of heparin therapy; Details of the clinical characteristics of patients involved in the study; Discussion on the management of patients who receive heparin therapy.

  • The end of the heparin pump? Grubb, Nell R; Bloomfield, Peter; Ludlam, Christopher A // BMJ: British Medical Journal (International Edition);12/05/98, Vol. 317 Issue 7172, p1540 

    Examines the effectivity of low molecular weight heparins in treating patients with venous thromboembolic disease and unstable angina. Details on antithrombotic therapy with intravenous unfractionated heparin; Benefits of heparin treatment; Information on unfractionated heparin; Comparison...

  • Disseminated Intravascular Coagulation During Heparin Therapy. Klein, Harvey G.; Bell, William R. // Annals of Internal Medicine;Apr74, Vol. 80 Issue 4, p477 

    Proposes mechanisms that might cause or prolong disseminated intravascular coagulation during heparin therapy. Possible cause of disseminated intravascular coagulation; Theory on heparin therapy; Doses of heparin that failed to prevent disseminated intravascular coagulation.

  • Improving the Safety of Heparin Therapy. Lohr, Lisa K. // Orthopedics;Apr2004, Vol. 27 Issue 4, p384 

    Presents recommendations for improving heparin safety. Background of heparin; Risk associated with heparin use; Potential strategies that could be implemented to reduce the risk of medication errors and harm from heparin; Information on strategies for change and assessment that hospitals...

  • Anticoagulant Treatment of Thromboembolism with Intravenous Heparin Therapy in the Early Postoperative Period Following Total Joint Arthroplasty. Della Valle, Craig J.; Jazrawi, Laith M.; Idjadi, Jeremy; Hiebert, Rudi N.; Stuchin, Steven A.; Steiger, David J.; Di Cesare, Paul E. // Journal of Bone & Joint Surgery, American Volume;Feb2000, Vol. 82-A Issue 2, p207 

    Background: Treatment of thromboembolism with intravenous heparin therapy in the early postoperative period after total joint arthroplasty has been associated with a high rate of complications. The purpose of the present study was to compare the rate of bleeding complications in a group of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics